Global Cephalosporin Drugs Market (2019-2025)

July 2019 | 300 pages | ID: G1BC41E3270EN
KBV Research

Abstracts

The Global Cephalosporin Drugs Market size is expected to reach $14.1 billion by 2025, rising at a market growth of 3.34% CAGR during the forecast period.

A Cephalosporin Drugs is a group of semi-synthetic, wide-spectrum antibiotics mainly used to treat infections of bacteria. Increasing the incidence of the population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea are the main variables contributing to market growth. Increasing R&D operations to create extremely effective & secure medicines and increasing the use of combination therapies further enhance the growth of the market. Nevertheless, the side effects of Cephalosporin Drugs and the development of drug-resistant bacterial strains restrict the growth of the market.

Cephalosporin Drugss are categorized together based on the category of bacteria against which they are most efficient. These groups are known as generations. The global Cephalosporin Drugs market is witnessing growth due to an increase in infectious disease incidence, increased R&D operations for combination drug development, and increased financing for antibiotic development. Furthermore, increasing demand for the antibacterial drives the global Cephalosporin Drugs drug market to grow further.

Based on Generation, the market is segmented into First-Generation Cephalosporin, Second-Generation Cephalosporin, Third-Generation Cephalosporin, Fourth-Generation Cephalosporin, and Fifth-Generation Cephalosporin. Based on Application, the market is segmented into Respiratory Tract Infection, Skin Infection, Ear Infection, Sexually Transmitted Infection and Others. Based on Route of Administration, the market is segmented into Injections and Oral Drugs. Based on Type, the market is segmented into Branded and Generic. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Teva Pharmaceuticals Industries Ltd., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, Baxter International, Inc., Bristol-Myers Squibb Company and Novartis AG.

Scope of the Study

Market Segmentation:

By Generation

• First-Generation Cephalosporin
• Second-Generation Cephalosporin
• Third-Generation Cephalosporin
• Fourth-Generation Cephalosporin
• Fifth-Generation Cephalosporin

By Application

• Respiratory Tract Infection
• Skin Infection
• Ear Infection
• Sexually Transmitted Infection
• Others

By Route of Administration

• Injections
• Oral Drugs

By Type

• Branded
• Generic

By Geography

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific
• LAMEA
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled

• ABBOTT Laboratories
• Teva Pharmaceuticals Industries Ltd.
• Johnson and Johnson
• GlaxoSmithKline PLC (GSK)
• Pfizer, Inc.
• Merck & Co., Inc.
• Bayer AG
• Baxter International, Inc.
• BRISTOL-MYERS SQUIBB COMPANY
• Novartis AG

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Contents

CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Global Cephalosporin Drugs Market, by Generation
  1.4.2 Global Cephalosporin Drugs Market, by Application
  1.4.3 Global Cephalosporin Drugs Market, by Route of Administration
  1.4.4 Global Cephalosporin Drugs Market, by Type
  1.4.5 Global Cephalosporin Drugs Market, by Geography
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. GLOBAL CEPHALOSPORIN DRUGS MARKET BY GENERATION

3.1 Global First-Generation Cephalosporin Drugs Market by Region
3.2 Global Second-Generation Cephalosporin Drugs Market by Region
3.3 Global Third-Generation Cephalosporin Drugs Market by Region
3.4 Global Fourth-Generation Cephalosporin Drugs Market by Region
3.5 Global Fifth-Generation Cephalosporin Drugs Market by Region

CHAPTER 4. GLOBAL CEPHALOSPORIN DRUGS MARKET BY APPLICATION

4.1 Global Respiratory Tract Infection Market by Region
4.2 Global Skin Infection Market by Region
4.3 Global Ear Infection Market by Region
4.4 Global Sexually Transmitted Infection Market by Region
4.5 Global Others Market by Region

CHAPTER 5. GLOBAL CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION

5.1 Global Injections Market by Region
5.2 Global Oral Drugs Market by Region

CHAPTER 6. GLOBAL CEPHALOSPORIN DRUGS MARKET BY TYPE

6.1 Global Branded Market by Region
6.2 Global Generic Market by Region

CHAPTER 7. GLOBAL CEPHALOSPORIN DRUGS MARKET BY REGION

7.1 North America Cephalosporin Drugs Market
  7.1.1 North America Cephalosporin Drugs Market by Generation
    7.1.1.1 North America First-Generation Cephalosporin Drugs Market by Country
    7.1.1.2 North America Second-Generation Cephalosporin Drugs Market by Country
    7.1.1.3 North America Third-Generation Cephalosporin Drugs Market by Country
    7.1.1.4 North America Fourth-Generation Cephalosporin Drugs Market by Country
    7.1.1.5 North America Fifth-Generation Cephalosporin Drugs Market by Country
  7.1.2 North America Cephalosporin Drugs Market by Application
    7.1.2.1 North America Respiratory Tract Infection Market by Country
    7.1.2.2 North America Skin Infection Market by Country
    7.1.2.3 North America Ear Infection Market by Country
    7.1.2.4 North America Sexually Transmitted Infection Market by Country
    7.1.2.5 North America Others Market by Country
  7.1.3 North America Cephalosporin Drugs Market by Route of Administration
    7.1.3.1 North America Injections Market by Country
    7.1.3.2 North America Oral Drugs Market by Country
  7.1.4 North America Cephalosporin Drugs Market by Type
    7.1.4.1 North America Branded Market by Country
    7.1.4.2 North America Generic Market by Country
  7.1.5 North America Cephalosporin Drugs Market by Country
    7.1.5.1 USA Cephalosporin Drugs Market
      7.1.5.1.1 USA Cephalosporin Drugs Market by Generation
      7.1.5.1.2 USA Cephalosporin Drugs Market by Application
      7.1.5.1.3 USA Cephalosporin Drugs Market by Route of Administration
      7.1.5.1.4 USA Cephalosporin Drugs Market by Type
    7.1.5.2 Canada Cephalosporin Drugs Market
      7.1.5.2.1 Canada Cephalosporin Drugs Market by Generation
      7.1.5.2.2 Canada Cephalosporin Drugs Market by Application
      7.1.5.2.3 Canada Cephalosporin Drugs Market by Route of Administration
      7.1.5.2.4 Canada Cephalosporin Drugs Market by Type
    7.1.5.3 Mexico Cephalosporin Drugs Market
      7.1.5.3.1 Mexico Cephalosporin Drugs Market by Generation
      7.1.5.3.2 Mexico Cephalosporin Drugs Market by Application
      7.1.5.3.3 Mexico Cephalosporin Drugs Market by Route of Administration
      7.1.5.3.4 Mexico Cephalosporin Drugs Market by Type
    7.1.5.4 Rest of North America Cephalosporin Drugs Market
      7.1.5.4.1 Rest of North America Cephalosporin Drugs Market by Generation
      7.1.5.4.2 Rest of North America Cephalosporin Drugs Market by Application
      7.1.5.4.3 Rest of North America Cephalosporin Drugs Market by Route of Administration
      7.1.5.4.4 Rest of North America Cephalosporin Drugs Market by Type
7.2 Europe Cephalosporin Drugs Market
  7.2.1 Europe Cephalosporin Drugs Market by Generation
    7.2.1.1 Europe First-Generation Cephalosporin Drugs Market by Country
    7.2.1.2 Europe Second-Generation Cephalosporin Drugs Market by Country
    7.2.1.3 Europe Third-Generation Cephalosporin Drugs Market by Country
    7.2.1.4 Europe Fourth-Generation Cephalosporin Drugs Market by Country
    7.2.1.5 Europe Fifth-Generation Cephalosporin Drugs Market by Country
  7.2.2 Europe Cephalosporin Drugs Market by Application
    7.2.2.1 Europe Respiratory Tract Infection Market by Country
    7.2.2.2 Europe Skin Infection Market by Country
    7.2.2.3 Europe Ear Infection Market by Country
    7.2.2.4 Europe Sexually Transmitted Infection Market by Country
    7.2.2.5 Europe Others Market by Country
  7.2.3 Europe Cephalosporin Drugs Market by Route of Administration
    7.2.3.1 Europe Injections Market by Country
    7.2.3.2 Europe Oral Drugs Market by Country
  7.2.4 Europe Cephalosporin Drugs Market by Type
    7.2.4.1 Europe Branded Market by Country
    7.2.4.2 Europe Generic Market by Country
  7.2.5 Europe Cephalosporin Drugs Market by Country
    7.2.5.1 Germany Cephalosporin Drugs Market
      7.2.5.1.1 Germany Cephalosporin Drugs Market by Generation
      7.2.5.1.2 Germany Cephalosporin Drugs Market by Application
      7.2.5.1.3 Germany Cephalosporin Drugs Market by Route of Administration
      7.2.5.1.4 Germany Cephalosporin Drugs Market by Type
    7.2.5.2 UK Cephalosporin Drugs Market
      7.2.5.2.1 UK Cephalosporin Drugs Market by Generation
      7.2.5.2.2 UK Cephalosporin Drugs Market by Application
      7.2.5.2.3 UK Cephalosporin Drugs Market by Route of Administration
      7.2.5.2.4 UK Cephalosporin Drugs Market by Type
    7.2.5.3 France Cephalosporin Drugs Market
      7.2.5.3.1 France Cephalosporin Drugs Market by Generation
      7.2.5.3.2 France Cephalosporin Drugs Market by Application
      7.2.5.3.3 France Cephalosporin Drugs Market by Route of Administration
      7.2.5.3.4 France Cephalosporin Drugs Market by Type
    7.2.5.4 Russia Cephalosporin Drugs Market
      7.2.5.4.1 Russia Cephalosporin Drugs Market by Generation
      7.2.5.4.2 Russia Cephalosporin Drugs Market by Application
      7.2.5.4.3 Russia Cephalosporin Drugs Market by Route of Administration
      7.2.5.4.4 Russia Cephalosporin Drugs Market by Type
    7.2.5.5 Spain Cephalosporin Drugs Market
      7.2.5.5.1 Spain Cephalosporin Drugs Market by Generation
      7.2.5.5.2 Spain Cephalosporin Drugs Market by Application
      7.2.5.5.3 Spain Cephalosporin Drugs Market by Route of Administration
      7.2.5.5.4 Spain Cephalosporin Drugs Market by Type
    7.2.5.6 Italy Cephalosporin Drugs Market
      7.2.5.6.1 Italy Cephalosporin Drugs Market by Generation
      7.2.5.6.2 Italy Cephalosporin Drugs Market by Application
      7.2.5.6.3 Italy Cephalosporin Drugs Market by Route of Administration
      7.2.5.6.4 Italy Cephalosporin Drugs Market by Type
    7.2.5.7 Rest of Europe Cephalosporin Drugs Market
      7.2.5.7.1 Rest of Europe Cephalosporin Drugs Market by Generation
      7.2.5.7.2 Rest of Europe Cephalosporin Drugs Market by Application
      7.2.5.7.3 Rest of Europe Cephalosporin Drugs Market by Route of Administration
      7.2.5.7.4 Rest of Europe Cephalosporin Drugs Market by Type
7.3 Asia Pacific Cephalosporin Drugs Market
  7.3.1 Asia Pacific Cephalosporin Drugs Market by Generation
    7.3.1.1 Asia Pacific First-Generation Cephalosporin Drugs Market by Country
    7.3.1.2 Asia Pacific Second-Generation Cephalosporin Drugs Market by Country
    7.3.1.3 Asia Pacific Third-Generation Cephalosporin Drugs Market by Country
    7.3.1.4 Asia Pacific Fourth-Generation Cephalosporin Drugs Market by Country
    7.3.1.5 Asia Pacific Fifth-Generation Cephalosporin Drugs Market by Country
  7.3.2 Asia Pacific Cephalosporin Drugs Market by Application
    7.3.2.1 Asia Pacific Respiratory Tract Infection Market by Country
    7.3.2.2 Asia Pacific Skin Infection Market by Country
    7.3.2.3 Asia Pacific Ear Infection Market by Country
    7.3.2.4 Asia Pacific Sexually Transmitted Infection Market by Country
    7.3.2.5 Asia Pacific Others Market by Country
  7.3.3 Asia Pacific Cephalosporin Drugs Market by Route of Administration
    7.3.3.1 Asia Pacific Injections Market by Country
    7.3.3.2 Asia Pacific Oral Drugs Market by Country
  7.3.4 Asia Pacific Cephalosporin Drugs Market by Type
    7.3.4.1 Asia Pacific Branded Market by Country
    7.3.4.2 Asia Pacific Generic Market by Country
  7.3.5 Asia Pacific Cephalosporin Drugs Market by Country
    7.3.5.1 China Cephalosporin Drugs Market
      7.3.5.1.1 China Cephalosporin Drugs Market by Generation
      7.3.5.1.2 China Cephalosporin Drugs Market by Application
      7.3.5.1.3 China Cephalosporin Drugs Market by Route of Administration
      7.3.5.1.4 China Cephalosporin Drugs Market by Type
    7.3.5.2 Japan Cephalosporin Drugs Market
      7.3.5.2.1 Japan Cephalosporin Drugs Market by Generation
      7.3.5.2.2 Japan Cephalosporin Drugs Market by Application
      7.3.5.2.3 Japan Cephalosporin Drugs Market by Route of Administration
      7.3.5.2.4 Japan Cephalosporin Drugs Market by Type
    7.3.5.3 India Cephalosporin Drugs Market
      7.3.5.3.1 India Cephalosporin Drugs Market by Generation
      7.3.5.3.2 India Cephalosporin Drugs Market by Application
      7.3.5.3.3 India Cephalosporin Drugs Market by Route of Administration
      7.3.5.3.4 India Cephalosporin Drugs Market by Type
    7.3.5.4 South Korea Cephalosporin Drugs Market
      7.3.5.4.1 South Korea Cephalosporin Drugs Market by Generation
      7.3.5.4.2 South Korea Cephalosporin Drugs Market by Application
      7.3.5.4.3 South Korea Cephalosporin Drugs Market by Route of Administration
      7.3.5.4.4 South Korea Cephalosporin Drugs Market by Type
    7.3.5.5 Singapore Cephalosporin Drugs Market
      7.3.5.5.1 Singapore Cephalosporin Drugs Market by Generation
      7.3.5.5.2 Singapore Cephalosporin Drugs Market by Application
      7.3.5.5.3 Singapore Cephalosporin Drugs Market by Route of Administration
      7.3.5.5.4 Singapore Cephalosporin Drugs Market by Type
    7.3.5.6 Malaysia Cephalosporin Drugs Market
      7.3.5.6.1 Malaysia Cephalosporin Drugs Market by Generation
      7.3.5.6.2 Malaysia Cephalosporin Drugs Market by Application
      7.3.5.6.3 Malaysia Cephalosporin Drugs Market by Route of Administration
      7.3.5.6.4 Malaysia Cephalosporin Drugs Market by Type
    7.3.5.7 Rest of Asia Pacific Cephalosporin Drugs Market
      7.3.5.7.1 Rest of Asia Pacific Cephalosporin Drugs Market by Generation
      7.3.5.7.2 Rest of Asia Pacific Cephalosporin Drugs Market by Application
      7.3.5.7.3 Rest of Asia Pacific Cephalosporin Drugs Market by Route of Administration
      7.3.5.7.4 Rest of Asia Pacific Cephalosporin Drugs Market by Type
7.4 LAMEA Cephalosporin Drugs Market
  7.4.1 LAMEA Cephalosporin Drugs Market by Generation
    7.4.1.1 LAMEA First-Generation Cephalosporin Drugs Market by Country
    7.4.1.2 LAMEA Second-Generation Cephalosporin Drugs Market by Country
    7.4.1.3 LAMEA Third-Generation Cephalosporin Drugs Market by Country
    7.4.1.4 LAMEA Fourth-Generation Cephalosporin Drugs Market by Country
    7.4.1.5 LAMEA Fifth-Generation Cephalosporin Drugs Market by Country
  7.4.2 LAMEA Cephalosporin Drugs Market by Application
    7.4.2.1 LAMEA Respiratory Tract Infection Market by Country
    7.4.2.2 LAMEA Skin Infection Market by Country
    7.4.2.3 LAMEA Ear Infection Market by Country
    7.4.2.4 LAMEA Sexually Transmitted Infection Market by Country
    7.4.2.5 LAMEA Others Market by Country
  7.4.3 LAMEA Cephalosporin Drugs Market by Route of Administration
    7.4.3.1 LAMEA Injections Market by Country
    7.4.3.2 LAMEA Oral Drugs Market by Country
  7.4.4 LAMEA Cephalosporin Drugs Market by Type
    7.4.4.1 LAMEA Branded Market by Country
    7.4.4.2 LAMEA Generic Market by Country
  7.4.5 LAMEA Cephalosporin Drugs Market by Country
    7.4.5.1 Brazil Cephalosporin Drugs Market
      7.4.5.1.1 Brazil Cephalosporin Drugs Market by Generation
      7.4.5.1.2 Brazil Cephalosporin Drugs Market by Application
      7.4.5.1.3 Brazil Cephalosporin Drugs Market by Route of Administration
      7.4.5.1.4 Brazil Cephalosporin Drugs Market by Type
    7.4.5.2 Argentina Cephalosporin Drugs Market
      7.4.5.2.1 Argentina Cephalosporin Drugs Market by Generation
      7.4.5.2.2 Argentina Cephalosporin Drugs Market by Application
      7.4.5.2.3 Argentina Cephalosporin Drugs Market by Route of Administration
      7.4.5.2.4 Argentina Cephalosporin Drugs Market by Type
    7.4.5.3 UAE Cephalosporin Drugs Market
      7.4.5.3.1 UAE Cephalosporin Drugs Market by Generation
      7.4.5.3.2 UAE Cephalosporin Drugs Market by Application
      7.4.5.3.3 UAE Cephalosporin Drugs Market by Route of Administration
      7.4.5.3.4 UAE Cephalosporin Drugs Market by Type
    7.4.5.4 Saudi Arabia Cephalosporin Drugs Market
      7.4.5.4.1 Saudi Arabia Cephalosporin Drugs Market by Generation
      7.4.5.4.2 Saudi Arabia Cephalosporin Drugs Market by Application
      7.4.5.4.3 Saudi Arabia Cephalosporin Drugs Market by Route of Administration
      7.4.5.4.4 Saudi Arabia Cephalosporin Drugs Market by Type
    7.4.5.5 South Africa Cephalosporin Drugs Market
      7.4.5.5.1 South Africa Cephalosporin Drugs Market by Generation
      7.4.5.5.2 South Africa Cephalosporin Drugs Market by Application
      7.4.5.5.3 South Africa Cephalosporin Drugs Market by Route of Administration
      7.4.5.5.4 South Africa Cephalosporin Drugs Market by Type
    7.4.5.6 Nigeria Cephalosporin Drugs Market
      7.4.5.6.1 Nigeria Cephalosporin Drugs Market by Generation
      7.4.5.6.2 Nigeria Cephalosporin Drugs Market by Application
      7.4.5.6.3 Nigeria Cephalosporin Drugs Market by Route of Administration
      7.4.5.6.4 Nigeria Cephalosporin Drugs Market by Type
    7.4.5.7 Rest of LAMEA Cephalosporin Drugs Market
      7.4.5.7.1 Rest of LAMEA Cephalosporin Drugs Market by Generation
      7.4.5.7.2 Rest of LAMEA Cephalosporin Drugs Market by Application
      7.4.5.7.3 Rest of LAMEA Cephalosporin Drugs Market by Route of Administration
      7.4.5.7.4 Rest of LAMEA Cephalosporin Drugs Market by Type

CHAPTER 8. COMPANY PROFILES

8.1 ABBOTT Laboratories
  8.1.1 Company Overview
  8.1.2 Financial Analysis
  8.1.3 Segmental and Regional Analysis
  8.1.4 Research & Development Expense
  8.1.1 Recent strategies and developments:
    8.1.1.1 Collaborations, partnerships and agreements:
    8.1.1.2 Acquisition and Mergers:
8.2 Teva Pharmaceutical Industries Ltd.
  8.2.1 Company Overview
  8.2.2 Financial Analysis
  8.2.3 Regional Analysis
  8.2.4 Research & Development Expenses
  8.2.5 Recent strategies and developments:
    8.2.5.1 Product launches:
8.3 Johnson and Johnson
  8.3.1 Company Overview
  8.3.2 Financial Analysis
  8.3.3 Segmental &Regional Analysis
  8.3.4 Research & Development Expenses
  8.3.5 Recent strategies and developments:
    8.3.5.1 Acquisition and Mergers:
8.4 GlaxoSmithKline PLC (GSK)
  8.4.1 Company Overview
  8.4.2 Financial Analysis
  8.4.3 Segmental and Regional Analysis
  8.4.4 Research & Development Expense
  8.4.5 Recent strategies and developments:
    8.4.5.1 Collaborations, partnerships and agreements:
    8.4.5.2 Expansion:
    8.4.5.3 Approval:
8.5 Pfizer, Inc.
  8.5.1 Company Overview
  8.5.2 Financial Analysis
  8.5.3 Segmental and Regional Analysis
  8.5.4 Research & Development Expense
  8.5.5 Recent strategies and developments:
    8.5.5.1 Collaborations, partnerships and agreements:
    8.5.5.2 Product launches:
    8.5.5.3 Acquisition and Mergers:
8.6 Merck & Co., Inc.
  8.6.1 Company Overview
  8.6.2 Financial Analysis
  8.6.3 Segmental and Regional Analysis
  8.6.4 Research & Development Expenses
  8.6.5 Recent strategies and developments:
    8.6.5.1 Collaborations, partnerships and agreements:
    8.6.5.2 Product launches:
8.7 Bayer AG (Bayer Schering Pharma AG)
  8.7.1 Company Overview
  8.7.2 Financial Analysis
  8.7.3 Segmental and Regional Analysis
  8.7.4 Research & Development Expense
  8.7.5 Recent strategies and developments:
    8.7.5.1 Collaborations, partnerships and agreements:
    8.7.5.2 Product launches:
8.8 Baxter International, Inc.
  8.8.1 Company Overview
  8.8.2 Financial Analysis
  8.8.3 Regional Analysis
  8.8.4 Research & Development Expense
  8.8.5 Recent strategies and developments:
    8.8.5.1 Product launches:
8.9 Bristol-Myers Squibb Company
  8.9.1 Company overview
  8.9.2 Financial Analysis
  8.9.3 Regional Analysis
  8.9.4 Research & Development Expense
  8.9.5 Recent strategies and developments:
    8.9.5.1 Collaborations, partnerships and agreements:
8.1 Novartis AG
  8.10.1 Company Overview
  8.10.2 Financial Analysis
  8.10.3 Segmental and Regional Analysis
  8.10.4 Research & Development Expense
  8.10.5 Recent strategies and developments:
    8.10.5.1 Product launches:
    8.10.5.2 Acquisition and Mergers:

List Of Tables

LIST OF TABLES

TABLE 1 GLOBAL CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 2 GLOBAL CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 3 GLOBAL CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 4 GLOBAL CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 5 GLOBAL FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 6 GLOBAL FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 7 GLOBAL SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 8 GLOBAL SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 9 GLOBAL THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 10 GLOBAL THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 11 GLOBAL FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 12 GLOBAL FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 13 GLOBAL FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 14 GLOBAL FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 15 GLOBAL CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 16 GLOBAL CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 17 GLOBAL RESPIRATORY TRACT INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 18 GLOBAL RESPIRATORY TRACT INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 19 GLOBAL SKIN INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 20 GLOBAL SKIN INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 21 GLOBAL EAR INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 22 GLOBAL EAR INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 23 GLOBAL SEXUALLY TRANSMITTED INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 24 GLOBAL SEXUALLY TRANSMITTED INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 25 GLOBAL OTHERS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 26 GLOBAL OTHERS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 27 GLOBAL CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 28 GLOBAL CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 29 GLOBAL INJECTIONS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 30 GLOBAL INJECTIONS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 31 GLOBAL ORAL DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 32 GLOBAL ORAL DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 33 GLOBAL CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 34 GLOBAL CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 35 GLOBAL BRANDED MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 36 GLOBAL BRANDED MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 37 GLOBAL GENERIC MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 38 GLOBAL GENERIC MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 39 GLOBAL CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 40 GLOBAL CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 41 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 42 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 43 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 44 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 45 NORTH AMERICA FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 46 NORTH AMERICA FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 47 NORTH AMERICA SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 48 NORTH AMERICA SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 49 NORTH AMERICA THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 50 NORTH AMERICA THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 51 NORTH AMERICA FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 52 NORTH AMERICA FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 53 NORTH AMERICA FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 54 NORTH AMERICA FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 55 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 NORTH AMERICA RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 58 NORTH AMERICA RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 59 NORTH AMERICA SKIN INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 60 NORTH AMERICA SKIN INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 61 NORTH AMERICA EAR INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 62 NORTH AMERICA EAR INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 63 NORTH AMERICA SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 64 NORTH AMERICA SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 65 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 66 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 67 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 68 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 69 NORTH AMERICA INJECTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 70 NORTH AMERICA INJECTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 71 NORTH AMERICA ORAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 72 NORTH AMERICA ORAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 73 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 74 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 75 NORTH AMERICA BRANDED MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 76 NORTH AMERICA BRANDED MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 77 NORTH AMERICA GENERIC MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 78 NORTH AMERICA GENERIC MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 79 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 80 NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 81 USA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 82 USA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 83 USA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 84 USA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 85 USA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 86 USA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 87 USA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 88 USA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 89 USA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 90 USA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 91 CANADA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 92 CANADA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 93 CANADA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 94 CANADA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 95 CANADA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 96 CANADA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 97 CANADA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 98 CANADA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 99 CANADA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 100 CANADA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 101 MEXICO CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 102 MEXICO CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 103 MEXICO CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 104 MEXICO CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 105 MEXICO CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 106 MEXICO CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 107 MEXICO CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 108 MEXICO CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 109 MEXICO CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 110 MEXICO CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 111 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 112 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 113 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 114 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 115 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 116 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 117 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 118 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 119 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 120 REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 121 EUROPE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 122 EUROPE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 123 EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 124 EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 125 EUROPE FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 126 EUROPE FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 127 EUROPE SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 128 EUROPE SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 129 EUROPE THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 130 EUROPE THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 131 EUROPE FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 132 EUROPE FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 133 EUROPE FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 134 EUROPE FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 135 EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 136 EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 137 EUROPE RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 138 EUROPE RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 139 EUROPE SKIN INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 140 EUROPE SKIN INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 141 EUROPE EAR INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 142 EUROPE EAR INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 143 EUROPE SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 144 EUROPE SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 145 EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 146 EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 147 EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 148 EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 149 EUROPE INJECTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 150 EUROPE INJECTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 151 EUROPE ORAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 152 EUROPE ORAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 153 EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 154 EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 155 EUROPE BRANDED MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 156 EUROPE BRANDED MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 157 EUROPE GENERIC MARKET BY COUNTRY, 2015 - 2018,USD MILLION
TABLE 158 EUROPE GENERIC MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 159 EUROPE CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 160 EUROPE CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 161 GERMANY CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 162 GERMANY CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 163 GERMANY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 164 GERMANY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 165 GERMANY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 166 GERMANY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 167 GERMANY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 168 GERMANY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 169 GERMANY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 170 GERMANY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 171 UK CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 172 UK CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 173 UK CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 174 UK CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 175 UK CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 176 UK CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 177 UK CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 178 UK CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 179 UK CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 180 UK CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 181 FRANCE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 182 FRANCE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 183 FRANCE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 184 FRANCE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 185 FRANCE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 186 FRANCE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 187 FRANCE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 188 FRANCE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 189 FRANCE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 190 FRANCE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 191 RUSSIA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 192 RUSSIA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 193 RUSSIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 194 RUSSIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 195 RUSSIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 196 RUSSIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 197 RUSSIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 198 RUSSIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 199 RUSSIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 200 RUSSIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 201 SPAIN CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 202 SPAIN CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 203 SPAIN CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 204 SPAIN CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 205 SPAIN CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 206 SPAIN CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 207 SPAIN CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 208 SPAIN CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 209 SPAIN CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 210 SPAIN CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 211 ITALY CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 212 ITALY CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 213 ITALY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 214 ITALY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 215 ITALY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 216 ITALY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 217 ITALY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 218 ITALY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 219 ITALY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 220 ITALY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 221 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 222 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 223 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 224 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 225 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 226 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 227 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 228 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 229 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 230 REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 231 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 232 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 233 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 234 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 235 ASIA PACIFIC FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 236 ASIA PACIFIC FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 237 ASIA PACIFIC SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 238 ASIA PACIFIC SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 239 ASIA PACIFIC THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 240 ASIA PACIFIC THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 241 ASIA PACIFIC FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 242 ASIA PACIFIC FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 243 ASIA PACIFIC FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 244 ASIA PACIFIC FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 245 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 246 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 247 ASIA PACIFIC RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 248 ASIA PACIFIC RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 249 ASIA PACIFIC SKIN INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 250 ASIA PACIFIC SKIN INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 251 ASIA PACIFIC EAR INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 252 ASIA PACIFIC EAR INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 253 ASIA PACIFIC SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 254 ASIA PACIFIC SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 255 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 256 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 257 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 258 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 259 ASIA PACIFIC INJECTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 260 ASIA PACIFIC INJECTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 261 ASIA PACIFIC ORAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 262 ASIA PACIFIC ORAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 263 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 264 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 265 ASIA PACIFIC BRANDED MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 266 ASIA PACIFIC BRANDED MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 267 ASIA PACIFIC GENERIC MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 268 ASIA PACIFIC GENERIC MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 269 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 270 ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 271 CHINA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 272 CHINA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 273 CHINA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 274 CHINA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 275 CHINA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 276 CHINA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 277 CHINA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 278 CHINA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 279 CHINA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 280 CHINA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 281 JAPAN CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 282 JAPAN CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 283 JAPAN CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 284 JAPAN CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 285 JAPAN CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 286 JAPAN CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 287 JAPAN CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 288 JAPAN CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 289 JAPAN CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 290 JAPAN CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 291 INDIA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 292 INDIA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 293 INDIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 294 INDIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 295 INDIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 296 INDIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 297 INDIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 298 INDIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 299 INDIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 300 INDIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 301 SOUTH KOREA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 302 SOUTH KOREA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 303 SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 304 SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 305 SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 306 SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 307 SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 308 SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 309 SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 310 SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 311 SINGAPORE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 312 SINGAPORE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 313 SINGAPORE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 314 SINGAPORE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 315 SINGAPORE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 316 SINGAPORE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 317 SINGAPORE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 318 SINGAPORE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 319 SINGAPORE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 320 SINGAPORE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 321 MALAYSIA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 322 MALAYSIA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 323 MALAYSIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 324 MALAYSIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 325 MALAYSIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 326 MALAYSIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 327 MALAYSIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 328 MALAYSIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 329 MALAYSIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 330 MALAYSIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 331 REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 332 REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 333 REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 334 REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 335 REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 336 REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 337 REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 338 REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 339 REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 340 REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 341 LAMEA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 342 LAMEA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 343 LAMEA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 344 LAMEA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 345 LAMEA FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 346 LAMEA FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 347 LAMEA SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 348 LAMEA SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 349 LAMEA THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 350 LAMEA THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 351 LAMEA FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 352 LAMEA FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 353 LAMEA FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 354 LAMEA FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 355 LAMEA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 356 LAMEA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 357 LAMEA RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 358 LAMEA RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 359 LAMEA SKIN INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 360 LAMEA SKIN INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 361 LAMEA EAR INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 362 LAMEA EAR INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 363 LAMEA SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 364 LAMEA SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 365 LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 366 LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 367 LAMEA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 368 LAMEA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 369 LAMEA INJECTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 370 LAMEA INJECTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 371 LAMEA ORAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 372 LAMEA ORAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 373 LAMEA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 374 LAMEA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 375 LAMEA BRANDED MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 376 LAMEA BRANDED MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 377 LAMEA GENERIC MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 378 LAMEA GENERIC MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 379 LAMEA CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 380 LAMEA CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 381 BRAZIL CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 382 BRAZIL CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 383 BRAZIL CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 384 BRAZIL CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 385 BRAZIL CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 386 BRAZIL CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 387 BRAZIL CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 388 BRAZIL CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 389 BRAZIL CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 390 BRAZIL CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 391 ARGENTINA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 392 ARGENTINA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 393 ARGENTINA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 394 ARGENTINA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 395 ARGENTINA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 396 ARGENTINA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 397 ARGENTINA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 398 ARGENTINA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 399 ARGENTINA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 400 ARGENTINA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 401 UAE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 402 UAE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 403 UAE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 404 UAE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 405 UAE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 406 UAE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 407 UAE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 408 UAE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 409 UAE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 410 UAE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 411 SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 412 SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 413 SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 414 SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 415 SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 416 SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 417 SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 418 SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 419 SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 420 SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 421 SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 422 SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 423 SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 424 SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 425 SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 426 SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 427 SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 428 SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 429 SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 430 SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 431 NIGERIA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 432 NIGERIA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 433 NIGERIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 434 NIGERIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 435 NIGERIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 436 NIGERIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 437 NIGERIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 438 NIGERIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 439 NIGERIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 440 NIGERIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 441 REST OF LAMEA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
TABLE 442 REST OF LAMEA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
TABLE 443 REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
TABLE 444 REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
TABLE 445 REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 446 REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 447 REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
TABLE 448 REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
TABLE 449 REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 450 REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 451 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 452 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 453 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 454 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 455 KEY INFORMATION – PFIZER, INC.
TABLE 456 KEY INFORMATION – MERCK & CO., INC.
TABLE 457 KEY INFORMATION – BAYER AG
TABLE 458 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 459 KEY INFORMATION – BRISTOL-MYERS SQUIBB COMPANY
TABLE 460 KEY INFORMATION – NOVARTIS AG

List Of Figures

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH